Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0XT0I
|
||||
Former ID |
DNC003475
|
||||
Drug Name |
BIA
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Non-insulin dependent diabetes [ICD10:E11.9] | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C20H20F3N3O5
|
||||
Canonical SMILES |
C1CN(CCN1CCC(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-])C3=CC=C<br />C(=C3)C(F)(F)F
|
||||
InChI |
1S/C20H20F3N3O5/c21-20(22,23)14-2-1-3-15(12-14)25-8-6-24(7-9-25)5-4-17(27)13-10-16(26(30)31)19(29)18(28)11-13/h1-3,10-12,28-29H,4-9H2
|
||||
InChIKey |
KVIVJQWOYSWCCZ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Catechol-O-methyl-transferase | Target Info | Inhibitor | [1] | |
BioCyc Pathway | L-dopa degradation | ||||
Dopamine degradation | |||||
Noradrenaline and adrenaline degradation | |||||
KEGG Pathway | Steroid hormone biosynthesis | ||||
Tyrosine metabolism | |||||
Metabolic pathways | |||||
Dopaminergic synapse | |||||
PANTHER Pathway | Adrenaline and noradrenaline biosynthesis | ||||
Dopamine receptor mediated signaling pathway | |||||
PathWhiz Pathway | Tyrosine Metabolism | ||||
WikiPathways | Methylation Pathways | ||||
Metapathway biotransformation | |||||
Estrogen metabolism | |||||
Biogenic Amine Synthesis | |||||
Dopamine metabolism | |||||
Phase II conjugation | |||||
Neurotransmitter Clearance In The Synaptic Cleft | |||||
References | |||||
REF 1 | The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.